AAAAAA
Results:
1-21
|
Results: 21
Authors:
Del Giudice, P
Dellamonica, P
Durant, J
Rahelinrina, V
Grobusch, MP
Janitschke, K
Dahan-Guedj, A
Le Fichoux, Y
Citation: P. Del Giudice et al., A case of gnathostomiasis in a European traveller returning from Mexico, BR J DERM, 145(3), 2001, pp. 487-489
Authors:
Gauthier-Clerc, M
Le Maho, Y
Gendner, JP
Durant, J
Handrich, Y
Citation: M. Gauthier-clerc et al., State-dependent decisions in long-term fasting king penguins, Aptenodytes patagonicus, during courtship and incubation, ANIM BEHAV, 62, 2001, pp. 661-669
Authors:
Chaix, C
Grenier-Sennelier, C
Clevenbergh, P
Durant, J
Schapiro, JM
Dellamonica, P
Durand-Zaleski, I
Citation: C. Chaix et al., Economic evaluation of drug resistance genotyping for the adaptation of treatment in HIV-infected patients in the VIRADAPT study, J ACQ IMM D, 24(3), 2000, pp. 227-231
Authors:
Clevenbergh, P
Durant, J
Halfon, P
del Giudice, P
Mondain, V
Montagne, N
Schapiro, JM
Boucher, CAB
Dellamonica, P
Citation: P. Clevenbergh et al., Persisting long-term benefit of genotype-guided treatment for HIV-infectedpatients failing HAART. The Viradapt study: week 48 follow-up, ANTIVIR TH, 5(1), 2000, pp. 65-70
Authors:
Gaskell, G
Allum, N
Bauer, M
Durant, J
Allansdottir, A
Bonfadelli, H
Boy, D
de Cheveigne, S
Fjaestad, B
Gutteling, JM
Hampel, J
Jelsoe, E
Jesuino, JC
Kohring, M
Kronberger, N
Midden, C
Nielsen, TH
Przestalski, A
Rusanen, T
Sakellaris, G
Torgersen, H
Twardowski, T
Wagner, W
Citation: G. Gaskell et al., Biotechnology and the European public, NAT BIOTECH, 18(9), 2000, pp. 935-938
Authors:
del Giudice, P
Bernard, E
Perrin, C
Bernardin, G
Fouche, R
Boissy, C
Durant, J
Dellamonica, P
Citation: P. Del Giudice et al., Unusual cutaneous manifestations of miliary tuberculosis, CLIN INF D, 30(1), 2000, pp. 201-204
Authors:
Clevenbergh, P
Durant, J
Garraffo, R
Chaillou, S
Cua, E
Dellamonica, P
Citation: P. Clevenbergh et al., Multiples aspects of VIH resistance to antiretroviral drugs., MED MAL INF, 30(9), 2000, pp. 551-564
Authors:
Durant, J
Clevenbergh, P
Garraffo, R
Halfon, P
Icard, S
Del Giudice, P
Montagne, N
Schapiro, JM
Dellamonica, P
Citation: J. Durant et al., Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the ViradaptStudy, AIDS, 14(10), 2000, pp. 1333-1339
Authors:
Durant, J
Citation: J. Durant, A right to know?, NEW SCI, 167(2245), 2000, pp. 41-41
Authors:
Halfon, P
Halimi, G
Bourliere, M
Ouzan, D
Durant, J
Khiri, H
Mercier, L
Gerolami, V
Cartouzou, G
Citation: P. Halfon et al., Integrity of the NS5A (amino acid 2209 to 2248) region in hepatitis C virus 1b patients non-responsive to interferon therapy, LIVER, 20(5), 2000, pp. 381-386
Authors:
Gaskell, G
Bauer, M
Durant, J
Allum, N
Citation: G. Gaskell et al., Worlds apart? The reception of genetically modified foods in Europe and the US (vol 287, pg 384, 1999), SCIENCE, 288(5472), 2000, pp. 1751-1751
Authors:
Durant, J
Citation: J. Durant, Darwin's ghost - The 'Origin of Species' updated, NY TIMES R, 2000, pp. 11-12
Authors:
Durant, J
Citation: J. Durant, The change in the weather - People, weather, and the science of climate, NY TIMES R, 2000, pp. 20-20
Authors:
Badiaga, S
Delmont, J
Brouqui, P
Janbon, F
Durant, J
Bosseray, A
Malvy, D
Bonnet, E
Sotto, A
Dydymski, S
Peyramond, D
Citation: S. Badiaga et al., Imported dengue: study of 44 cases observed in 9 french university hospitals between 1994 and 1997., PATH BIOL, 47(5), 1999, pp. 539-542
Authors:
Durant, J
Clevenbergh, PH
Schapiro, JM
Dellamonica, P
Citation: J. Durant et al., Drug-resistant genotyping in HIV-1 therapy - Reply, LANCET, 354(9184), 1999, pp. 1120-1120
Authors:
Durant, J
Citation: J. Durant, Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial (vol 353, pg 2195, 1999), LANCET, 354(9184), 1999, pp. 1128-1128
Authors:
Durant, J
Clevenbergh, P
Halfon, P
Delgiudice, P
Porsin, S
Simonet, P
Montagne, N
Boucher, CAB
Schapiro, JM
Dellamonica, P
Citation: J. Durant et al., Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial, LANCET, 353(9171), 1999, pp. 2195-2199
Authors:
Gaskell, G
Bauer, MW
Durant, J
Allum, NC
Citation: G. Gaskell et al., Worlds apart? The reception of genetically modified foods in Europe and the US, SCIENCE, 285(5426), 1999, pp. 384-387
Authors:
Durant, J
Citation: J. Durant, Debating Darwin - Adventures of a scholar, NY TIMES R, 1999, pp. 28-28
Authors:
del Giudice, P
Durant, J
Counillon, E
Mondain, V
Bernard, E
Roger, PM
Dellamonica, P
Citation: P. Del Giudice et al., Mycobacterial cutaneous manifestations: A new sign of immune restoration syndrome in patients with acquired immunodeficiency syndrome, ARCH DERMAT, 135(9), 1999, pp. 1129-1130
Authors:
Chaillou, S
Durant, J
Clevenbergh, P
Rahelinirina, V
Garraffo, R
Schapiro, JM
Dellamonica, P
Citation: S. Chaillou et al., Long term effectiveness of Saquinavir and Ritonavir low dosage (baby-dose)in HIV patients failing combination therapy: correlation of response to treatment with genotype mutations and pharmacological data, SEVENTH EUROPEAN CONFERENCE ON CLINICAL ASPECTS AND TREATMENT OF HIV-INFECTION, 1999, pp. 69-72
Risultati:
1-21
|